InvestorsHub Logo
Followers 1
Posts 205
Boards Moderated 0
Alias Born 04/23/2012

Re: DUBUKU20 post# 5796

Tuesday, 02/26/2013 9:45:16 AM

Tuesday, February 26, 2013 9:45:16 AM

Post# of 32544
I'm expecting PSID to win the Contract, Aren't-you..

The Final Request For Proposal for BioWatcj Generation 3 Performance Testing, during Stage 1, is expected to be released in the government's third quarter of fiscal 2013, which ends June 30th.

The Stage 1 contract is expected to have a performance testing period of 18 months.

The full roll-out of BioWatch Generation 3 is estimated at $3.1 billion over the next five years.
http://investors.positiveidcorp.com/releasedetail.cfm?releaseid=738584

Performance-testing for the current-BioWatch-Gen-3 solicitation is 18 months, during the first stage of the competition.

The procurement for BioWatch Gen-3 Phase II will occur in two stages, DHS said.

The first stage involves performance testing of proposed biodetector systems competing against each other.

The period of performance testing for the current BioWatch Gen-3 solicitation is only 18 months, during the first stage of the competition.

The second phase, of the competition, involves operational testing and evaluation as well as production, deployment, sustainment and disposal.

DHS will only be making final one award for the second-stage of the BioWatch Gen-3 Competitive Down Selection.

Hopefully, PSID will be chosen as the one, and only winner during this Final Request For Proposal Phase of The Competition..

DHS asked interested companies to submit questions on the draft RFP by Feb. 11

Consulting firm Deltek, Herndon, Va., listed BioWatch Gen-3 as the only DHS program in its top 20 federal opportunities for contractors in fiscal year 2013. BioWatch Gen-3 represents a potential $3.1 billion value over five years, according to Deltek's estimates.

The DHS Office of Health Affairs runs the BioWatch program in partnership with the Environmental Protection Agency, the FBI and the Centers for Disease Control and Prevention.
http://www.hstoday.us/focused-topics/information-technology/single-article-page/more-info-on-biowatch-3-revealed-in-draft-solicitation.html

bull_investor Sunday, February 24, 2013 12:06:53 PM
Re: colocowboy post# 5794 Post #5796 of 5917

From GAO documents.

Estimated Schedule for Key Remaining Gen-3 Deployment Steps (as of September 2012):

ADE 2B:

Q4 2013 -to- Q2 2015 -- Laboratory Performance testing

Q4 2015 -to- Q3 2016 -- Operational testing, including IT network.

ADE 3:

Q4 2016 -to- Q1 2022 -- Production of approx. 2500 Gen-3 units and phased deployment to 50 jurisdictions

Q3 2022 -- Full operational capability.

** ADE - Acquisition Decision Event
** Q - Fiscal year quarter
Source: GAO Analysis of BioWatch program documents.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=84947393

bull_investor Monday, February 18, 2013 8:30:39 AM
Re: None Post #5347 of 5917

Lets Break Down the Basics (BDB)-

==> Two key terms:

1 - RFP : solicitation through bidding process, here the solicitor knows what he wants, in this RFP, everything is listed, including price, risk factors, what is achievable and what is not. This is step 1 of procurement, a sure deal. according to news release this date could be on or before June 30 2013

2 - DRAFT RFP : is not a formal solicitation tool, rather it is used to gather comments and suggestions from potential offerors. The DRFP is mandatory for all competitive acquisitions expected to exceed $25 million; it is optional for all other acquisitions. It is designed to reduce proposal preparation and evaluation time and promote a clearer understanding to industry of the requirements with a goal of a more effective and less costly contract.

Now note those "two key terms" in the Feb 6, 2013 news release:

http://investors.positiveidcorp.com/releasedetail.cfm?releaseid=738584

Title: PositiveID Reports Issuance of Draft RFP From Dept of Homeland Security for BioWatch Generation 3

PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of biological detection and diagnostics solutions, today announced that the U.S. Department of Homeland Security ("DHS") released a draft request for proposal ("RFP") for Stage 1 of BioWatch Generation 3, an autonomous biodetection system designed to protect the nation against biological threats. The final RFP for Stage 1 is expected to be released in the government's third quarter of fiscal 2013, which ends June 30th. The Stage 1 contract is expected to have a performance period of 18 months. The full roll-out of BioWatch Generation 3 is estimated at $3.1 billion over the next five years.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=84707176

bull_investor Sunday, February 24, 2013 11:25:42 AM
Re: Robsct post# 5787 Post #5792 of 5917

DHS PDF says:

"The Government anticipates awarding multiple contracts for Stage 1.
However, only one contract will be awarded under Stage 2
after a competive down selection between stages"

It says one contract for Stage 2 - what does one contract mean??
is it one vendor? or
can a contract be of multiple vendors(PSID & NOC)?

if it is one vendor, then most likely it is PSID,
since CEO was saying that in past press releases!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=84946722




Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.